4th Quarter - Report

RED+BLUE STRATEGIES for PEW CHARITABLE TRUSTS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 6 - 21st Century Cures Act - Issues related to ensuring that medically needed antibiotics are available to the public, curbing opioid abuse in Medicare Part D and maintaining the integrity of the federal Open Payments program. S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation. Support of the inclusion of Advanced Care Planning codes in the CMS Physician Fee Schedule (PFS). S. 633 - The Promise for antibiotics and Therapeutics for Health (PATH) Act - Focused on ensuring that the Food and Drug Administration has the necessary to tools to ensure that medically needed antibiotics are made available to the public. Issues related to ending prescription drug abuse and diversion in Medicare and Medicaid. Advancing provisions to highlight Antibiotic Innovation in the President's FY 2016 budget. issues related to pricing of prescription medications.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 6 (114th), S. 633 (114th), S. 1549 (114th)

Health Issues HCR

H.R. 6 - 21st Century Cures Act - Issues related to ensuring that medically needed antibiotics are available to the public, curbing opioid abuse in Medicare Part D and maintaining the integrity of the federal Open Payments program. S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation. H.R. 2029; PL 114-13 - Consolidated Appropriations Act of FY2016 - Issues related to the use of the unique device identifier tool to most effectively enhance safety and efficacy for patients and providers. Support of the inclusion of Advanced Care Planning codes in the CMS Physician Fee Schedule (PFS). S. 633 - The Promise for antibiotics and Therapeutics for Health (PATH) Act - Focused on ensuring that the Food and Drug Administration has the necessary to tools to ensure that medically needed antibiotics are made available to the public. Regulatory issues surrounding unique device identifiers (UDI) being addressed by CMS, FDA and ONC. Regulatory issues related to Meaningful Use 3 as it could related to the utilization of UDIs. Exploring new policies to improve end of life care in America. Issues related to ending prescription drug abuse and diversion in Medicare and Medicaid. Advancing provisions to highlight Antibiotic Innovation in the President's FY 2016 budget. Supporting policies to maintain the integrity of laws regarding compounding of certain medications.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2029 (114th), S. 633 (114th), H.R. 6 (114th), S. 1549 (114th)

Medicare/Medicaid MMM

H.R. 6 - 21st Century Cures Act - Issues related to curbing opioid abuse in Medicare Part D and maintaining the integrity of the federal Open Payments program. S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation. H.R. 2029; PL 114-13 - Consolidated Appropriations Act of FY2016 - Issues related to the use of the unique device identifier tool to most effectively enhance safety and efficacy for patients and providers. Support of the inclusion of Advanced Care Planning codes in the CMS Physician Fee Schedule (PFS). Regulatory issues surrounding unique device identifiers (UDI) being addressed by CMS, FDA and ONC. Regulatory issues related to Meaningful Use 3 as it could related to the utilization of UDIs. Exploring new policies to improve end of life care in America. Issues related to ending prescription drug abuse and diversion in Medicare and Medicaid.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Bills named: H.R. 2029 (114th), H.R. 6 (114th), S. 1549 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.